Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. It also provides food and technical grade purified phosphoric acid (PPA) used in the production of phosphate salts, as well as in food and beverages, and water treatment applications; technical grade sodium tripolyphosphate (STPP), a specialty phosphate, which is used as an ingredient in cleaning products, such as industrial and institutional cleaners, automatic dishwashing detergents, and consumer laundry detergents, as well as in water treatment, clay processing, and copper ore processing activities; and detergent grade PPA that is primarily used in the production of STPP. In addition, the company offers granular triple super-phosphate (GTSP), a fertilizer product line used for enhancing crop yields in various agricultural sectors; and merchant green phosphoric acid. It serves primarily consumer goods manufacturers, distributors, and specialty chemical manufacturers in the United States, Canada, Mexico, and internationally. Innophos Holdings, Inc. was founded in 2004 and is headquartered in Cranbury, New Jersey.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:IPHS
CUSIP45774N10
Phone609-495-2495
Debt
Debt-to-Equity Ratio0.99
Current Ratio2.75
Quick Ratio1.34
Price-To-Earnings
Trailing P/E Ratio17.75
Forward P/E Ratio15.66
P/E GrowthN/A
Sales & Book Value
Annual Sales$722.02 million
Price / Sales1.19
Cash Flow$4.5643 per share
Price / Cash9.57
Book Value$17.08 per share
Price / Book2.56
Profitability
EPS (Most Recent Fiscal Year)$2.46
Net Income$22.44 million
Net Margins2.21%
Return on Equity14.28%
Return on Assets6.13%
Miscellaneous
Employees1,373
Outstanding Shares19,610,000
Market Cap$859.24 million
Innophos (NASDAQ:IPHS) Frequently Asked Questions
What is Innophos' stock symbol?
Innophos trades on the NASDAQ under the ticker symbol "IPHS."
How often does Innophos pay dividends? What is the dividend yield for Innophos?
Innophos announced a quarterly dividend on Tuesday, July 31st. Stockholders of record on Friday, August 17th will be given a dividend of $0.48 per share on Wednesday, September 5th. This represents a $1.92 annualized dividend and a dividend yield of 4.40%. The ex-dividend date of this dividend is Thursday, August 16th. View Innophos' Dividend History.
How were Innophos' earnings last quarter?
Innophos Holdings, Inc. (NASDAQ:IPHS) issued its earnings results on Monday, July, 30th. The specialty chemicals company reported $0.55 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.65 by $0.10. The specialty chemicals company had revenue of $206.73 million for the quarter, compared to analyst estimates of $213.40 million. Innophos had a net margin of 2.21% and a return on equity of 14.28%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.57 EPS. View Innophos' Earnings History.
When is Innophos' next earnings date?
What is the consensus analysts' recommendation for Innophos?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Innophos.
Who are some of Innophos' key competitors?
Who are Innophos' key executives?
Innophos' management team includes the folowing people:
- Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 58)
- Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 52)
- Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 50)
- Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 41)
- Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 42)
Has Innophos been receiving favorable news coverage?
Media stories about IPHS stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innophos earned a news impact score of 0.06 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 46.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for Innophos.
Who are Innophos' major shareholders?
Innophos' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.59%), Segall Bryant & Hamill LLC (5.71%), Dimensional Fund Advisors LP (5.28%), Frontier Capital Management Co. LLC (4.25%), Renaissance Technologies LLC (3.85%) and American Century Companies Inc. (3.20%). View Institutional Ownership Trends for Innophos.
Which major investors are selling Innophos stock?
IPHS stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Renaissance Technologies LLC, Fuller & Thaler Asset Management Inc., Frontier Capital Management Co. LLC, Boston Partners, Granite Investment Partners LLC, Martingale Asset Management L P and Chartwell Investment Partners LLC. View Insider Buying and Selling for Innophos.
Which major investors are buying Innophos stock?
IPHS stock was purchased by a variety of institutional investors in the last quarter, including Investment Counselors of Maryland LLC, BlackRock Inc., Deprince Race & Zollo Inc., Wells Fargo & Company MN, Algert Global LLC, WBI Investments Inc., Segall Bryant & Hamill LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for Innophos.
How do I buy shares of Innophos?
Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innophos' stock price today?
One share of IPHS stock can currently be purchased for approximately $43.68.
How big of a company is Innophos?
Innophos has a market capitalization of $859.24 million and generates $722.02 million in revenue each year. The specialty chemicals company earns $22.44 million in net income (profit) each year or $2.46 on an earnings per share basis. Innophos employs 1,373 workers across the globe.
How can I contact Innophos?
Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]
MarketBeat Community Rating for Innophos (NASDAQ IPHS)
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
